Pharmafile Logo
Pharmafocus logo
Advanced Search

EU

Showing 15 posts of 252 posts found.

Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

News

MHRA leads social media drug safety initiative

September 8, 2014
Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr

The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …

News
european_flag

Europe warned over cancer research risk

July 27, 2014
Medical Communications, Research and Development, Sales and Marketing ESMO, EU, Macmillan, data

A leading European doctors’ group is warning that new data protection rules could make cancer research ‘impossible’ whilst also adding …

News
Abbvie image

AbbVie hep C treatment fast-tracked

June 18, 2014
Research and Development, Sales and Marketing AbbVie, Abbott, EMA, EU, Gilead, HCV, hep C, sovaldi

The European regulator is to fast-track AbbVie’s oral, interferon-free treatment for adults with chronic genotype 1 (GT1) hepatitis C virus …

News
Esbriet image

InterMune drops EMA lawsuit over data release

June 10, 2014
Research and Development, Sales and Marketing EMA, EU, Esbriet, Goldacre, InterMune, alltrials, lung

InterMune has ended a year-long legal spat with the European Medicines Agency over the potential release of data for its …

News
Avastin image

EU looks at eye drug allegations

May 8, 2014
Sales and Marketing EU, Lucentis, Novartis, Roche, avastin, offlabel

European Union regulators are considering whether they need to take any action over the recent allegations of anti-competitiveness involving Roche …

News
Ema image

EMA to conduct major review into testosterone drugs

April 14, 2014
Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

News
Glenis Willmott

EU votes for trial transparency

April 3, 2014
Research and Development, Sales and Marketing ABPI, EFPIA, EU, Goldacre, UK, alltrials, transparency, willmott

Europe took a decisive step toward forcing pharma to open up its clinical trial data last night, after the EU …

News

CHMP recommends Jardiance

March 24, 2014
Research and Development, Sales and Marketing Boehringer, CHMP, EU, diabetes, jardiance, lilly

Boehringer Ingelheim and Eli Lilly’s type 2 diabetes treatment Jardiance is among nine medicines which the Committee for Medicinal Products …

News
EU flag image

Data transparency debate: Europe decides its future

March 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, EU, Goldacre, NHS, alltrials, european, transparency

Transparency became a major issue in 2013 as various new pressure groups sprung up with the shared aim of forcing …

Feature

Europe: TB treatment ‘far below’ target

March 19, 2014
Research and Development, Sales and Marketing EU, MDR TB, TB, WHO, tuberculosis

European countries are still not getting to grips with the diagnosis and treatment of tuberculosis, according to a new report …

News
EFPIA Bergstrom image

EFPIA targets MEPs in social media campaign

March 17, 2014
Medical Communications, Sales and Marketing EFPIA, EU, bergstrom, pharma summit, social media

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has launched a social media campaign aimed at MEPs. With ten …

News
Biogen Idec image

Biogen Idec’s MS drug gets European approval

February 4, 2014
Manufacturing and Production, Sales and Marketing Aubagio, Biogen IDEC, EU, MS, gilenya, tecdifera

Biogen Idec’s oral multiple sclerosis drug Tecfidera has won approval in Europe as a first-line treatment for people with relapsing-remitting …

News
Teva image

Teva’s Great White Hope knocked back by Europe

January 27, 2014
Sales and Marketing CHMP, EU, MS, Nerventra, Teva

The drug designed to be a follow-up to Teva’s wildly successful Copaxone has been hit by rejection in Europe, leaving …

News
Aubagio image

NICE recommends Aubagio

January 22, 2014
Sales and Marketing Aubagio, EU, FDA, NICE, Sanofi, gilenya

NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025